211 related articles for article (PubMed ID: 33966638)
1. Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy.
Cong L; Maishi N; Annan DA; Young MF; Morimoto H; Morimoto M; Nam JM; Hida Y; Hida K
Breast Cancer Res; 2021 May; 23(1):51. PubMed ID: 33966638
[TBL] [Abstract][Full Text] [Related]
2. Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression.
Andrlová H; Mastroianni J; Madl J; Kern JS; Melchinger W; Dierbach H; Wernet F; Follo M; Technau-Hafsi K; Has C; Rao Mittapalli V; Idzko M; Herr R; Brummer T; Ungefroren H; Busch H; Boerries M; Narr A; Ihorst G; Vennin C; Schmitt-Graeff A; Minguet S; Timpson P; Duyster J; Meiss F; Römer W; Zeiser R
Oncotarget; 2017 Jun; 8(26):42901-42916. PubMed ID: 28476030
[TBL] [Abstract][Full Text] [Related]
3. Expression of Biglycan in First Trimester Chorionic Villous Sampling Placental Samples and Altered Function in Telomerase-Immortalized Microvascular Endothelial Cells.
Chui A; Gunatillake T; Brennecke SP; Ignjatovic V; Monagle PT; Whitelock JM; van Zanten DE; Eijsink J; Wang Y; Deane J; Borg AJ; Stevenson J; Erwich JJ; Said JM; Murthi P
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1168-1179. PubMed ID: 28408374
[TBL] [Abstract][Full Text] [Related]
4. Biglycan and chondroitin sulfate play pivotal roles in bone toughness via retaining bound water in bone mineral matrix.
Hua R; Ni Q; Eliason TD; Han Y; Gu S; Nicolella DP; Wang X; Jiang JX
Matrix Biol; 2020 Dec; 94():95-109. PubMed ID: 33002580
[TBL] [Abstract][Full Text] [Related]
5. Biglycan modulates angiogenesis and bone formation during fracture healing.
Berendsen AD; Pinnow EL; Maeda A; Brown AC; McCartney-Francis N; Kram V; Owens RT; Robey PG; Holmbeck K; de Castro LF; Kilts TM; Young MF
Matrix Biol; 2014 Apr; 35():223-31. PubMed ID: 24373744
[TBL] [Abstract][Full Text] [Related]
6. Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatin.
Myren M; Kirby DJ; Noonan ML; Maeda A; Owens RT; Ricard-Blum S; Kram V; Kilts TM; Young MF
Matrix Biol; 2016; 52-54():141-150. PubMed ID: 27072616
[TBL] [Abstract][Full Text] [Related]
7. Biglycan deficiency interferes with ovariectomy-induced bone loss.
Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
[TBL] [Abstract][Full Text] [Related]
8. Tumor endothelial cells accelerate tumor metastasis.
Maishi N; Hida K
Cancer Sci; 2017 Oct; 108(10):1921-1926. PubMed ID: 28763139
[TBL] [Abstract][Full Text] [Related]
9. Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice.
Sun X; Gupta K; Wu B; Zhang D; Yuan B; Zhang X; Chiang HC; Zhang C; Curiel TJ; Bendeck MP; Hursting S; Hu Y; Li R
J Biol Chem; 2018 Feb; 293(8):2841-2849. PubMed ID: 29298894
[TBL] [Abstract][Full Text] [Related]
10. Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway.
Hu L; Zang MD; Wang HX; Li JF; Su LP; Yan M; Li C; Yang QM; Liu BY; Zhu ZG
Mol Oncol; 2016 Nov; 10(9):1473-1484. PubMed ID: 27590684
[TBL] [Abstract][Full Text] [Related]
11. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
[No Abstract] [Full Text] [Related]
12. Biglycan-deficient mice have delayed osteogenesis after marrow ablation.
Chen XD; Allen MR; Bloomfield S; Xu T; Young M
Calcif Tissue Int; 2003 May; 72(5):577-82. PubMed ID: 12724831
[TBL] [Abstract][Full Text] [Related]
13. Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells.
Yoshimura T; Howard OM; Ito T; Kuwabara M; Matsukawa A; Chen K; Liu Y; Liu M; Oppenheim JJ; Wang JM
PLoS One; 2013; 8(3):e58791. PubMed ID: 23527025
[TBL] [Abstract][Full Text] [Related]
14. Potential use of human adipose mesenchymal stromal cells for intervertebral disc regeneration: a preliminary study on biglycan-deficient murine model of chronic disc degeneration.
Marfia G; Campanella R; Navone SE; Zucca I; Scotti A; Figini M; Di Vito C; Alessandri G; Riboni L; Parati E
Arthritis Res Ther; 2014 Oct; 16(5):457. PubMed ID: 25293819
[TBL] [Abstract][Full Text] [Related]
15. Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy.
Vaxevanis CK; Bauer M; Subbarayan K; Friedrich M; Massa C; Biehl K; Al-Ali HK; Wickenhauser C; Seliger B
Oncoimmunology; 2023; 12(1):2152998. PubMed ID: 36531688
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.
Schulz GB; Grimm T; Sers C; Riemer P; Elmasry M; Kirchner T; Stief CG; Karl A; Horst D
Urol Oncol; 2019 Aug; 37(8):530.e9-530.e18. PubMed ID: 31176613
[TBL] [Abstract][Full Text] [Related]
17. Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction.
Liu B; Xu T; Xu X; Cui Y; Xing X
Mol Cell Biochem; 2018 Dec; 449(1-2):285-294. PubMed ID: 29761248
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study.
Zheng S; Liang JY; Tang Y; Xie J; Zou Y; Yang A; Shao N; Kuang X; Ji F; Liu X; Tian W; Xiao W; Lin Y
Clin Transl Med; 2023 Feb; 13(2):e1189. PubMed ID: 36772945
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Biglycan is Associated with Resistance to Rapamycin in Human WERI-Rb-1 Retinoblastoma Cells by Inducing the Activation of the Phosphatidylinositol 3-Kinases (PI3K)/Akt/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Fang D; Lai Z; Wang Y
Med Sci Monit; 2019 Sep; 25():6639-6648. PubMed ID: 31483776
[TBL] [Abstract][Full Text] [Related]
20. Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly.
Chen S; Young MF; Chakravarti S; Birk DE
Matrix Biol; 2014 Apr; 35():103-11. PubMed ID: 24447998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
